Literature DB >> 8370753

Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques.

M Puolakkainen1, C C Kuo, A Shor, S P Wang, J T Grayston, L A Campbell.   

Abstract

The antigen-specific serological response to Chlamydia pneumoniae was studied in 45 adults with coronary artery atherosclerosis and compared with that in 40 adults with acute respiratory infection. C. pneumoniae antigen and DNA were detected in lesions more frequently in patients with low immunoglobulin G titers against C. pneumoniae than in those with high immunoglobulin G titers. Reactivities with the 42-kDa (46%) and 52-kDa (31%) proteins were observed more frequently in sera from seropositive individuals with atherosclerosis than in sera from patients with acute respiratory infection. Antibodies against the C. pneumoniae-specific 42- and/or 52-kDa protein may be a marker for chronic C. pneumoniae infection.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8370753      PMCID： PMC265726          DOI： 10.1128/jcm.31.8.2212-2214.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Serological response to Chlamydia pneumoniae infection.

Authors:  L A Campbell; C C Kuo; S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 5.  A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston; L A Campbell; C C Kuo; C H Mordhorst; P Saikku; D H Thom; S P Wang
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

6.  Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease.

Authors:  D H Thom; S P Wang; J T Grayston; D S Siscovick; D K Stewart; R A Kronmal; N S Weiss
Journal:  Arterioscler Thromb       Date:  1991 May-Jun

7.  Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease.

Authors:  D H Thom; J T Grayston; D S Siscovick; S P Wang; N S Weiss; J R Daling
Journal:  JAMA       Date:  1992-07-01       Impact factor: 56.272

8.  Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease.

Authors:  E Linnanmäki; M Leinonen; K Mattila; M S Nieminen; V Valtonen; P Saikku
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

9.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

10.  Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.

Authors:  A Shor; C C Kuo; D L Patton
Journal:  S Afr Med J       Date:  1992-09
  10 in total
  29 in total

1.  Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens.

Authors:  M Smieja; J B Mahony; C H Goldsmith; S Chong; A Petrich; M Chernesky
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

Authors:  L A Jackson; L A Campbell; R A Schmidt; C C Kuo; A L Cappuccio; M J Lee; J T Grayston
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Heat-inactivated C. pneumoniae organisms are not atherogenic.

Authors:  Jyotika Sharma; Yuhong Niu; Jianbo Ge; Grant N Pierce; Guangming Zhong
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

Review 4.  Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

Authors:  Margareta M Ieven; Vicky Y Hoymans
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

5.  Atherosclerosis due to chronic arteritis caused by Chlamydia pneumoniae: a tentative hypothesis.

Authors:  W Stille; R Dittmann; G Just-Nübling
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

6.  Simplified preparation of human arterial sections for PCR analysis of Chlamydia pneumoniae and human DNA.

Authors:  D Palfrey; P J Cook; J A Smythe; G Y Lip; A V Hine
Journal:  Mol Pathol       Date:  1999-10

7.  Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months.

Authors:  L Liu; H Hu; H Ji; A D Murdin; G N Pierce; G Zhong
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

8.  Evaluation of Chlamydia pneumoniae 43- and 53-kilodalton recombinant proteins for serodiagnosis by Western Blot.

Authors:  L A Campbell; S Roberts; S Inoue; L Kong; C C Kuo Cc
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

9.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.

Authors:  P Patel; M A Mendall; D Carrington; D P Strachan; E Leatham; N Molineaux; J Levy; C Blakeston; C A Seymour; A J Camm
Journal:  BMJ       Date:  1995-09-16

10.  Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model.

Authors:  Ulla Airaksinen; Tuula Penttilä; Eva Wahlström; Jenni M Vuola; Mirja Puolakkainen; Matti Sarvas
Journal:  Clin Diagn Lab Immunol       Date:  2003-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.